Ameriprise’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,500
Closed -$21.3K 4130
2025
Q2
$21.3K Sell
23,500
-23,397
-50% -$13.9K ﹤0.01% 3939
2025
Q1
$21.2K Buy
46,897
+4,019
+9% +$2.36K ﹤0.01% 3980
2024
Q4
$21.5K Buy
42,878
+19,378
+82% +$14.2K ﹤0.01% 4046
2024
Q3
$21.3K Sell
23,500
-160
-0.7% -$148 ﹤0.01% 3906
2024
Q2
$23.6K Hold
23,660
﹤0.01% 3837
2024
Q1
$35K Sell
23,660
-2,000
-8% -$2.27K ﹤0.01% 3821
2023
Q4
$28K Hold
25,660
﹤0.01% 3866
2023
Q3
$30.3K Sell
25,660
-14
-0.1% -$19 ﹤0.01% 3856
2023
Q2
$36.2K Hold
25,674
﹤0.01% 3877
2023
Q1
$38.5K Buy
25,674
+14
+0.1% +$20 ﹤0.01% 3881
2022
Q4
$30K Sell
25,660
-43,600
-63% -$54.9K ﹤0.01% 3881
2022
Q3
$78K Buy
69,260
+28,600
+70% +$42K ﹤0.01% 3862
2022
Q2
$64K Buy
+40,660
New +$53.6K ﹤0.01% 3816
2022
Q1
Sell
-304,989
Closed -$747K 3991
2021
Q4
$747K Buy
+304,989
New +$714K ﹤0.01% 3381
2018
Q3
Sell
-42,973
Closed -$78K 3755
2018
Q2
$78K Sell
42,973
-30,939
-42% -$62.3K ﹤0.01% 3583
2018
Q1
$172K Buy
73,912
+3,469
+5% +$8.13K ﹤0.01% 3506
2017
Q4
$133K Sell
70,443
-1,955
-3% -$4.27K ﹤0.01% 3536
2017
Q3
$180K Buy
72,398
+20,637
+40% +$51.2K ﹤0.01% 3534
2017
Q2
$142K Buy
+51,761
New +$145K ﹤0.01% 3620
2014
Q4
Sell
-9,280
Closed -$24K 4089
2014
Q3
$24K Buy
9,280
+8,896
+2,317% +$21.4K ﹤0.01% 4394
2014
Q2
$1K Buy
+384
New +$867 ﹤0.01% 5352
2013
Q4
Sell
-2,852
Closed -$9K 5300
2013
Q3
$9K Hold
2,852
﹤0.01% 4976
2013
Q2
$9K Buy
+2,852
New +$9.14K ﹤0.01% 4856

Other funds holding LCTX